163 related articles for article (PubMed ID: 19761697)
1. Up-regulation of CXC chemokine receptor 4 expression in chronic atrial fibrillation patients with mitral valve disease may be attenuated by renin-angiotensin system blockers.
Wang XX; Zhang FR; Zhu JH; Xie XD; Chen JZ
J Int Med Res; 2009; 37(4):1145-51. PubMed ID: 19761697
[TBL] [Abstract][Full Text] [Related]
2. Precise Drug Sequential Therapy Can Improve the Cardioversion Rate of Atrial Fibrillation with Valvular Disease after Radiofrequency Ablation.
Li T; Qian Y
Methods Mol Biol; 2020; 2204():145-159. PubMed ID: 32710322
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
[TBL] [Abstract][Full Text] [Related]
4. Circulating and local renin-angiotensin-aldosterone system express differently in atrial fibrillation patients with different types of mitral valvular disease.
Qian Y; Liu Y; Tang H; Zhou W; Jiang L; Li Y; Li N; Li M; Xiao X
J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):204-11. PubMed ID: 23077077
[TBL] [Abstract][Full Text] [Related]
5. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation.
Tsai CT; Lai LP; Hwang JJ; Chen WP; Chiang FT; Hsu KL; Tseng CD; Tseng YZ; Lin JL
J Hypertens; 2008 Mar; 26(3):570-82. PubMed ID: 18300870
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
[TBL] [Abstract][Full Text] [Related]
8. Unraveling regulatory mechanisms of atrial remodeling of mitral regurgitation pigs by gene expression profiling analysis: role of type I angiotensin II receptor antagonist.
Chen MC; Chang JP; Chang TH; Hsu SD; Huang HD; Ho WC; Wang FS; Hsiao CC; Liu WH
Transl Res; 2015 May; 165(5):599-620. PubMed ID: 25500755
[TBL] [Abstract][Full Text] [Related]
9. Differential structural remodeling of the left-atrial posterior wall in patients affected by mitral regurgitation with or without persistent atrial fibrillation: a morphological and molecular study.
Corradi D; Callegari S; Maestri R; Ferrara D; Mangieri D; Alinovi R; Mozzoni P; Pinelli S; Goldoni M; Privitera YA; Bartoli V; Astorri E; Macchi E; Vaglio A; Benussi S; Alfieri O
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):271-9. PubMed ID: 21954878
[TBL] [Abstract][Full Text] [Related]
10. ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation.
Boldt A; Scholl A; Garbade J; Resetar ME; Mohr FW; Gummert JF; Dhein S
Basic Res Cardiol; 2006 May; 101(3):261-7. PubMed ID: 16382287
[TBL] [Abstract][Full Text] [Related]
11. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease.
Boldt A; Wetzel U; Weigl J; Garbade J; Lauschke J; Hindricks G; Kottkamp H; Gummert JF; Dhein S
J Am Coll Cardiol; 2003 Nov; 42(10):1785-92. PubMed ID: 14642689
[TBL] [Abstract][Full Text] [Related]
12. Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling.
Liu E; Xu Z; Li J; Yang S; Yang W; Li G
Int J Cardiol; 2011 Feb; 146(3):364-70. PubMed ID: 19732978
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation.
Cong H; Li X; Ma L; Jiang H; Mao Y; Xu M
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):298-304. PubMed ID: 20080265
[TBL] [Abstract][Full Text] [Related]
14. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease.
Goette A; Lendeckel U
J Am Coll Cardiol; 2004 Jun; 43(12):2363; author reply 2363-4. PubMed ID: 15193707
[No Abstract] [Full Text] [Related]
15. Preventive effect of renin-angiotensin system inhibitor on left atrial remodelling in patients with chronic atrial fibrillation: long-term echocardiographic study.
Fukuda Y; Fukuda N; Morishita S; Tamura Y
Eur J Echocardiogr; 2011 Apr; 12(4):278-82. PubMed ID: 21266378
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory gene expression in patients undergoing mitral valve surgery and maze ablation for atrial fibrillation.
Tsai FC; Chang GJ; Hsu YJ; Lin YM; Lee YS; Chen WJ; Kuo CT; Yeh YH
J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1673-1682.e5. PubMed ID: 26774166
[TBL] [Abstract][Full Text] [Related]
17. Identification of atrial fibrillation-associated microRNAs in left and right atria of rheumatic mitral valve disease patients.
Yan Y; Shi R; Yu X; Sun C; Zang W; Tian H
Genes Genet Syst; 2019 Apr; 94(1):23-34. PubMed ID: 30584185
[TBL] [Abstract][Full Text] [Related]
18. Direct pro-arrhythmogenic effects of angiotensin II can be suppressed by AT1 receptor blockade in human atrial myocardium.
von Lewinski D; Kockskämper J; Rübertus SU; Zhu D; Schmitto JD; Schöndube FA; Hasenfuss G; Pieske B
Eur J Heart Fail; 2008 Dec; 10(12):1172-6. PubMed ID: 18993115
[TBL] [Abstract][Full Text] [Related]
19. The role of renin angiotensin system blockade in the treatment of atrial fibrillation.
Dilaveris P; Giannopoulos G; Synetos A; Stefanadis C
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Oct; 5(5):387-403. PubMed ID: 16248831
[TBL] [Abstract][Full Text] [Related]
20. [Study on levels of angiotensin converting enzyme and C-reactive protein in peripheral blood of mitral valve replacement preoperative patients with atrial fibrillation].
Qian YJ; Xiao XJ; Luo TX; Zhu P; Sao HZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):122-5. PubMed ID: 18390218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
